中文 | 日本語
tel

What's New

Home > Latest

  • Shanghai FTZ to lead pilot on global standards cooperation

    2026-10-13

    The China (Shanghai) Pilot Free Trade Zone is among five pilot free trade zones and free trade ports approved by the general offices of the State Administration for Market Regulation and the Ministry of Commerce for China's first batch of pilot programs for independent opening-up in standardization.

  • Embodied intelligence skills competition to be held in Shanghai

    2026-10-08

    A skill competition focused on embodied intelligence, bringing together technologies, ideas, and ecosystems from across the sector, will be held in Shanghai from Oct 23 to Oct 25.

  • Healthcare firms from Pudong to unveil innovations at 2026 CIIE

    2026-09-22

    Healthcare firms from Pudong to unveil innovations at 2026 CIIE With the ninth China International Import Expo less than 50 days away, multinational healthcare companies in Shanghai's Pudong New Area are preparing to showcase innovative medicines and medical technologies, including products developed through local research and innovation partnerships. Medtronic, which has participated in every CIIE, will display about 120 products and solutions spanning cardiovascular care, neuroscience, surgery and diabetes care — its largest lineup at the expo — with seven making their debut. Highlights include a locally developed orthopedic surgical navigation and positioning system that integrates navigation and robotic modes, and “Honghu", a single-use powered linear cutting stapler developed to meet clinical needs in China. AstraZeneca will occupy a 1,000-square-meter booth in the medical devices and healthcare exhibition area. Across the expo's first eight editions, the company has introduced 20 products making their China debuts. One breast cancer drug showcased in 2025 was approved, commercially launched and included in medical insurance within eight months. The company plans to invest more than 100 billion yuan ($14.9 billion) in China by 2030 and will present additional therapies for cancer, chronic diseases and rare diseases at this year's expo. Boehringer Ingelheim, exhibiting for the eighth consecutive year, will showcase 10 products and solutions in human pharmaceuticals and animal health, several making their China debuts. Its plans to expand in China include establishing a new research and development center in Zhangjiang and localizing production of its drug Jascayd (nerandomilast). The new center is expected to strengthen collaboration with China's biotech sector and accelerate the development of innovative therapies.

  • Shanghai targets major global hub for consumption, trade by 2030

    2026-09-20

    Shanghai will further consolidate its position as a global trade center by 2030, outlining a series of targets to enhance its appeal as a global consumption hub through high-standard opening-up, according to officials.

  • Pudong Airport tops Asia-Pacific connectivity ranking

    2026-09-10

    Shanghai Pudong International Airport ranked first in air connectivity across the Asia-Pacific region in 2025.

  • HKU's Zhangjiang campus expands with second phase

    2026-09-03

    The second phase of the University of Hong Kong (HKU)'s Zhangjiang campus in Shanghai's Pudong New Area opened on Aug 30, expanding the university's activities related to teaching, research, and innovation in the city.

  • AI helps drive industrial upgrading in Waigaoqiao

    2026-09-03

    Artificial intelligence is accelerating industrial upgrading in Shanghai's Waigaoqiao bonded area, where a growing number of companies are combining AI with logistics, healthcare, advanced manufacturing, and other sectors.

  • Shanghai business cooperation zone streamlines cross-border travel

    2026-09-02

    ​The Shanghai Eastern Hub International Business Cooperation Zone has introduced streamlined customs and immigration procedures to make it easier for overseas businesspeople to enter, leave, and conduct activities in the zone.

1 2 3 ... 162 >